Resource Logo

Surfactant therapy improves pulmonary function in infants with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.


Pediatr Pulmonol. 1997 Nov;24(5):370-3. Unique Identifier : AIDSLINE

Pneumocystis carinii pneumonia (PCP) is an important cause of acute respiratory failure in HIV-infected children. PCP may initiate acute respiratory distress syndrome (ARDS) by adversely affecting surfactant physiology. We report improved pulmonary function following administration of bovine lipid extract surfactant to two infants with AIDS-related PCP/ARDS.

*AIDS-Related Opportunistic Infections/DRUG THERAPY *Pneumonia, Pneumocystis carinii/DRUG THERAPY *Pulmonary Surfactants/THERAPEUTIC USE *Respiratory Distress Syndrome/DRUG THERAPY


Information in this article was accurate in March 30, 1998. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.